Article Details
Retrieved on: 2021-03-25 11:01:48
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
IMV to leverage Mr. Kuvalanka's industry expertise as it advances its lead immunotherapy toward potential registration and commercialization.
Article found on: vancouversun.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here